REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centro De Neurociencias Del Caribe Sas (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Ambulatory Health Care Services | Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities | Other Residential Care Facilities
Full name: Centro De Neurociencias Del Caribe Sas Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro De Neurociencias Del Caribe Sas is an enterprise located in Colombia, with the main office in Magangue. It operates in the General Medical and Surgical Hospitals industry. The company was established on October 25, 2021. The company’s latest financial report indicates a net sales revenue increase of 21.66% in 2023. Its’ total assets recorded a growth of 28.42%. The net profit margin of Centro De Neurociencias Del Caribe Sas increased by 1.7% in 2023.

Headquarters
Cl 14 46 50 Brr Miraflores
Magangue; Bolivar;

Contact Details: Purchase the Centro De Neurociencias Del Caribe Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Neurociencias Del Caribe Sas report to view the information.
Incorporation Date:
October 25, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Neurociencias Del Caribe Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
21.66%▲
Total operating revenue
21.66%▲
Operating profit (EBIT)
161.77%▲
Net Profit (Loss) for the Period
136.57%▲
Total assets
28.42%▲
Total equity
25.71%▲
Operating Profit Margin (ROS)
3.5%▲
Net Profit Margin
1.7%▲
Return on Equity (ROE)
9.58%▲
Quick Ratio
0.02%▲
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo